Quercetin as a Bitter Taste Receptor Agonist with Anticancer Effects in Head and Neck Cancer Cells

Abstract

Insights

Quercetin, a compound found in plants, activates bitter taste receptors (T2Rs) in head and neck squamous cell carcinoma (HNSCC) cells. This activation reduces cancer cell viability and triggers mitochondrial depolarization, suggesting a potential anticancer role for quercetin in HNSCC.

Area of Science:

  • Oncology
  • Cell Biology
  • Pharmacology

Background:

  • Quercetin exhibits anticancer properties in preclinical models of head and neck squamous cell carcinoma (HNSCC).
  • Bitter taste receptors (T2Rs) are expressed in HNSCC cells and their activation by bitter compounds like quercetin can induce apoptosis.
  • Increased T2R expression in HNSCC correlates with improved patient survival.

Purpose of the Study:

  • To investigate quercetin's role as an anticancer T2R agonist in HNSCC cells.
  • To assess the effects of quercetin on calcium (Ca 2+ ) signaling, cell viability, and mitochondrial function in HNSCC.

Main Methods:

  • Calcium imaging was used to assess quercetin-mediated Ca 2+ responses in HNSCC cell lines, with and without T2R14 antagonist LF1 and G-protein inhibitor YM-254980 (YM).
  • Cell viability was evaluated using crystal violet and MTS assays in cell lines and patient-derived tumor slices.
  • Mitochondrial depolarization was measured using TMRE in the presence and absence of T2R pathway inhibitors.

Main Results:

  • Quercetin induced a significant Ca 2+ response in HNSCC cells, which was attenuated by LF1 and YM.
  • Quercetin reduced cell viability in vitro and showed a trend towards decreased viability in tumor slices.
  • Quercetin treatment led to mitochondrial depolarization, an effect reduced by LF1 but not YM.

Conclusions:

  • Quercetin elicits a Ca 2+ response in HNSCC cells, likely mediated by T2R14.
  • Quercetin decreases HNSCC cell viability and induces mitochondrial depolarization.
  • These findings support quercetin's potential as an anticancer agent targeting T2Rs in HNSCC.

Related Concept Videos

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
588
The Physiology of Taste01:24

The Physiology of Taste

The perception of a salty flavor is facilitated by sodium ions within the oral salivary fluid. Upon consumption of a salty substance, salt crystals disassemble, leading to the liberation of its constituents—Na+ and Cl- ions. These ions subsequently dissolve into the salivary fluid present in the oral cavity. The external environment of the gustatory cells experiences an elevation in Na+ concentration, thereby establishing a potent concentration gradient. This gradient propels the...
7.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
602
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
7.7K